Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acoustic neurinoma
acoustic neurinoma, bilateral
acquired immunodeficiency syndrome
adrenoleukodystrophy
advances in neurology
adverse drug reaction
Alexanders disease
algorithm
Alzheimer's disease
Alzheimer's disease, familial
amniocentesis
amyloid angiopathy, cerebral
amyloid angiopathy, hereditary cystatin C
attention deficit disorder with hyperactivity
audiogram
auditory evoked brainstem potentials
basal ganglia, degeneration
basal ganglia, lesion of
Bassen-Kornzweig syndrome
brain biopsy
brainstem, lesion of
bulbar palsy, progressive
calcification, intracranial
CAT scan, emission
CAT scan, emission, abnormal
cataracts
cerebellar lesion
cerebro hepato renal syndrome
cerebrovascular accident
cerebrovascular accident, familial occurrence
cerebrovascular accident, young adult
Charcot-Marie-Tooth
children
chromosomal abnormality
chromosome 17
chromosome 22
chromosome 9
Cockayne's syndrome
cost effectiveness
creatine phosphokinase(CPK)elevated
cryptococcal meningitis
cytomegalovirus infection
dentate nuclei
dentate nuclei, lesion of
DNA probes
drug induced neurologic disorders
dystonia
dystonia musculorum deformens
dystrophin
ear, abnormal
electronystagmography
electroretinograph
encephalitis
encephalitis, focal
encephalitis, Rasmussen's
encephalitis, viral
enzyme, muscle disease
ependymoma
face, elongated
facial appearance, abnormal
familial
fasciculation
fragile-X syndrome
fundus, abnormality of
gadolinium
gene
gene mutation
genetic counselling
genetic diagnosis, prenatal
genetic linkage
genetic neurologic disorders
genetic screening
genetic testing
gynecomastia
Hallervorden Spatz disease
hearing loss
hemiparesis
hepatolenticular degeneration(Wilson's disease)
Huntington's chorea
Huntington's chorea, genetic counselling
Huntington's chorea, late onset
Huntington's chorea, presymptomatic detection of
Huntington's disease, children
hyperactivity
imbalance
immunohistochemistry
immunoperoxidase staining
in situ hybridization
inclusion bodies, intracytopasmic
intracerebral hemorrhage
intracerebral hemorrhage, familial
intracerebral hemorrhage, young adult
joint hypermobility
Kearns-Sayre syndrome
Kugelberg-Welander syndrome
Laurence-Moon-Bardet-Biedl syndrome
leukodystrophy
leukoencephalopathy
macular degeneration
manic-depressive
meningioma
meningitis
meningitis, recurrent
meningitis, relapse
mental retardation
mental retardation, familial
misdiagnosis
molecular genetics
mongolism
motor neuron disease
MRI
MRI, abnormal
MRI, contrast enhanced
mucopolysaccharidoses
muscle biopsy
muscular dystrophy
muscular dystrophy, Becker
muscular dystrophy, differential diagnosis of
muscular dystrophy, Duchenne
muscular dystrophy, Duchenne, carrier
muscular dystrophy, Duchenne, neonatal screening
muscular dystrophy, Duchenne, presymptomatic detection
muscular dystrophy, female occurrence of
muscular dystrophy, limb-girdle
myopathy, mitochondrial
myopia
myotonia dystrophica
neonatal screening, genetic neurologic disorders
neoplasm, intracranial
neoplasm, intracranial, multiple
neoplasm, primary of CNS
neoplasm, primary of CNS-multiple
nerve growth factor
neurofibromatosis 1
neurofibromatosis 2
neurofibromatosis 2, presymptomatic
neurologic disease
neurologic disease, diagnoses of
neuronal ceroid-lipofuscinosis
neuropathology
neuropathy
neuropathy, amyloid
neuropathy, hereditary peripheral
neuropathy, peripheral
neurotransmitter
night blindness
optic atrophy
optic nerve
optic neuropathy
patient information and support
peptides, brain
peroxisomal disease
pigmentary retinopathy
polymerase chain reaction
polyneuropathy, familial
posterior fossa, lesion of
pregnancy, neurologic complications in
prenatal diagnosis by amniocentesis
prognosis
progressive multifocal leucoencephalopathy
progressive spinal muscular atrophy
psychological testing
psychological testing, neurologic problems
recombinant DNA
recurrent
refractive errors
Refsum's disease
retinal degeneration
retinal lesion
retinitis pigmentosa
retinopathy
review article
RFLPs
Rosenthal fibers
seizure
seizure, focal
seizure, intractable, treatment of
sensorineural hearing loss
simian crease
somatostatin
Southern immunoblot test
spinal muscular atrophy
spinocerebellar degeneration
tapetoretinal degeneration
testicular enlargement
tinnitus
treatment of neurologic disorder
Usher's syndrome
viral infection
viral infection, CNS
visual field defect
visual loss
visuospatial disturbance
Von Hippel Lindau
Von Hippel Lindau, carrier
Von Hippel Lindau, screening protocol for
Western immunoblot test
white matter disease
Wood's light
X-linked bulbospinal neuronopathy
X-linked neuropathy
Showing articles 500 to 550 of 885 << Previous Next >>

Multiple Cerebral Microbleeds:MRI Marker of a Diffuse Hemorrhage-Prone State
J Neuroimaging 14:54-57, Chalela,J.A.,et al, 2004

Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke
Stroke 35:147-150, Brown,D.L.,et al, 2004

Intra-Arterial Thrombolysis of Complete Deep Cerebral Venous Thrombosis
Neurol 63:2444-2445, Liebetrau,M.,et al, 2004

Should Thrombolysis be Given to a Stroke Patient Refusing Therapy Due to Profound Anosognosia?
Neurol 63:2440, Katz,J.M. &Segal,A.Z., 2004

Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice
Stroke 34:2847-2850, Graham,G.D., 2003

Are Some Patients Likely to Benefit From Recombinant Tissue-Type Plasminogen Activator for Acute Ischemic Stroke Even Beyond 3 Hours From Symptom Onset?
Stroke 34:464-467, Kent,D.M.,et al, 2003

Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke
Stroke 34:575-583, Schellinger,P.D.,et al, 2003

Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural Residents
Stroke 34:729, Silliman,S.L.,et al, 2003

Telemedicine for Acute Stroke
Stroke 34:725, LaMonte,M.P.,et al, 2003

Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003

Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003

Stereotactic Treatment of Intracerebral Hematoma by Means of a Plasminogen Activator
Stroke 34:968-974, Teernstra,O.P.M.,et al, 2003

Cuahoga County Operation Stroke Speed of Emergency Department Evaluation and Compliance with National Institutes of Neurological Disorders and Stroke Time Targets
Stroke 34:994-998, Katzan,I.L.,et al, 2003

Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality
Stroke 34:1106-1113, Heuschmann,P.U.,et al, 2003

Pre- and In-Hospital Delays From Stroke Onset to Intra-arterial Thrombolysis
Stroke 34:1230-1234, Nedeltchev,K.,et al, 2003

Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients
Stroke 34:1235-1241, Alvarez-Sabin,J.,et al, 2003

Hemi-orolingual Angioedema and ACE Inhibition After Alteplase Treatment of Stroke
Neurol 60:1525-1527,1403, Hill,M.D.,et al, 2003

Immediate Reocclusion Following a Successful Thrombolysis in Acute Stroke: A Pilot Study
Neurol 60:1684-1687, Heo,J.H.,et al, 2003

Intra-arterial Thrombolysis in 24 Consecutive Patients with Internal Carotid Artery T Occlusions
JNNP 74:739-742, Arnold,M.,et al, 2003

Impact of Establishing a Primary Stroke Center at a Community Hospital on the Use of Thrombolytic Therapy
Stroke 34:e55, Lattimore,S.U.,et al, 2003

Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue
Stroke 34:1425-1430, Shih,L.C.,et al, 2003

Arterial Thrombosis Induced by IVIg and Its Treatment with tPA
Neurol 60:1825-1826,1736, Okuda,D.,et al, 2003

Efficacy of IV Tisuse Plasminogen Activator in Acute Stroke
Neurol 61:71-75, Hsia,A.W.,et al, 2003

Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
Stroke 34:1923-1924, Higashida,R.T.,et al, 2003

"Computed Tomography-Negative" Intracerebral Hemorrhage
Arch Neurol 60:1156-1159, Packard,A.S.,et al, 2003

Combined Stent Placement and Thrombolysis in Acute Vertebrobasilar Ischemic Stroke
AJNR 24:1827-1833, Lin,D.D.M.,et al, 2003

Magnetic Resonance Imaging Detection of Microbleeds Before Thrombolysis
Stroke 33:95-98, Kidwell,C.S.,et al, 2002

Clinical and Sonographic Patterns of Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion in Tissue Plasminogen Activator-Treated Patients
Stroke 33:99-102, El-Mitwalli,A.,et al, 2002

Acute Intravenou-Intra-Arterial Revascularization Therapy for Severe Ischemic Stroke
Stroke 33:279-282, Hill,M.D.,et al, 2002

Thrombolysis in Stroke Beyond Three Hours: Targeting Patients With Diffusion and Perfusion MRI
Ann Neurol 51:11-13,28, Warach,S., 2002

Cyclists' Doping Associated with Cerebral Sinus Thrombosis
Neurol 58:665, Lage,J.M.M.,et al, 2002

Magnetic Resonance Imaging in Basilar Artery Occlusion
Arch Neurol 59:398-402, du Mesnil de Rochemont,R.,et al, 2002

Predictors of Hemorrhagic Transformation in Patients Receiving Intra-Arterial Thrombolysis
Stroke 33:717-724, Kidwell,C.S.,et al, 2002

Recent Developments in Neurology
BMJ 324:656-660, Wiebe,S.,&Nicolle,M.W., 2002

Changes in Blood Flow and Oxygen Metabolism During Visual Stimulation in Carotid Artery Disease
Stroke 33:1294-1300, Yamauchi,H.,et al, 2002

Acute Basilar Artery Occlusion Treated with Combined Intravenous Abciximab and Intra-arterial Tissue Plaminogen Activator
Stroke 33:1424-1427, Eckert,B.,et al, 2002

Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke
Stroke 33:1437-1441, Ringleb,P.A.,et al, 2002

Thrombolysis in Patients with Acute Stroke Caused by Cervical Artery Dissection
Arch Neurol 59:549-553, Arnold,M.,et al, 2002

Alteplase for Stroke: Money and Optimistic Claims Buttress the "Brain Attack" Campaign
BMJ 324:723-729, Lenzer,J., 2002

Prognostic Accuracy of Cerebral Blood Flow Measurement by Perfusion Computed Tomography, at the Time of Emergency Room Admission, in Acute Stroke Patients
Ann Neurol 51:417-432,415, Wintermark,M.,et al, 2002

Computed Tomographic Findings in Patients Undergoing Intra-arterial Thrombolysis for Acute Ischemic Stroke Due to Middle Cerebral Artery Occlusion
Stroke 33:1557-1567, Roberts,H.C.,et al, 2002

Thrombolysis-Related Hemorrhagic Infarction
Stroke 33:1551-1556,1446, Molina,C.A.,et al, 2002

Clinical and Vascular Outcome in Internal Carotid Artery Versus Middle Cerebral Artery Occlusions After Intravenous Tissue Plasminogen Activator
Stroke 33:2066-2071, Linfante, I.,et al, 2002

Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients
Stroke 33:2025-2031, Wintermark,M.,et al, 2002

Predictors of Hemorrhagic Transformation After Intravenous Recombinant Tissue Plasminogen Activator
Stroke 33:2047-2052, Selim,M.,et al, 2002

Intra-Arterial Thrombolysis in 100 Patients With Acute Stroke Due to Middle Cerebral Artery Occlusion
Stroke 33:1828-1833, Arnold,M.,et al, 2002

Response of Intra-Arterial and Combined Intravenous and Intra-Arterial Thrombolytic Therapy in Patients with Distal Internal Carotid Artery Occlusion
Stroke 33:1821-1826,1827, Zaidat,O.O,et al, 2002

Signs of Acute Stroke Seen on Fluid-Attenuated Inversion Recovery MR Imaging
AJR 179:237-243, Makkat,S.,et al, 2002

Admission Glucose Level and Clinical Outcomes in the NINDS rt-PA Stroke Trial
Neurol 59:669-674, Bruno,A.,et al, 2002



Showing articles 500 to 550 of 885 << Previous Next >>